Showing results (1171-1180 of 1,272) with videos related to
Sort By:
Pageof 128
Acta Neuropathologica Communications|April 14, 2025
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasisSwaminathan Kumar, Meredith S Pelster, Merve Hasanov, et al.Nature Communications|May 10, 2024
Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenesAna Vieira, Yu Wan, Yan Ryan, et al.Journal of the American Veterinary Medical Association|November 16, 2024
Identification of raccoon rabies virus variant in a stray kitten: the role of veterinary practitioners in detection and reporting of a non-native zoonotic pathogen-Nebraska, 2023Ann Carpenter, Emma R Price, Sydney R Stein, et al.Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|January 31, 2025
A best practice guide for conducting healthy food retail research: A resource for researchers and health promotion practitionersTailane Scapin, Tara Boelsen-Robinson, Shaan Naughton, et al.Neuro-Oncology Advances|April 28, 2023
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experienceTimothy A Gregory, Maximilian Mastall, Heather Lin, et al.Gut|June 28, 2020
Loss of hepatic Mboat7 leads to liver fibrosisVeera Raghavan Thangapandi, Oskar Knittelfelder, Mario Brosch, et al.Neuro-Oncology|December 13, 2022
Changes in outcomes and factors associated with survival in melanoma patients with brain metastasesMerve Hasanov, Denái R Milton, Alicia Bea Davies, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
Oncogenic drivers shape the tumor microenvironment in human gliomasBo Zhao, Chae Yun Cho, Lingqun Ye, et al.Neuro-Oncology|November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophagesJohn de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.Pageof 128